BORRBangladesh Open Research Repository
SearchSubmitAboutContact
BORRResearch for a Better Bangladesh.
AboutSubmit PaperContactTermsPolicyGitHub

© 2026 Bangladesh Open Research Repository.

Filters

Sort By

Sort by relevanceSort by dateSort by citations
Year Range
to

Results for “"Joshua P. Vogel"”

13 results

Global, regional, and national estimates of levels of preterm birth in 2014: a systematic review and modelling analysis

Verified

Saifon Chawanpaiboon, Joshua P. Vogel, Ann‐Beth Moller, Pisake Lumbiganon et al.

Journal: The Lancet Global HealthYear: 2018Citations: 3138

BACKGROUND: Preterm birth is the leading cause of death in children younger than 5 years worldwide. Although preterm survival rates have increased in high-income countries, preterm newborns still die because of a lack of adequate newborn care in many low-income and middle-income countries. We estima...

Health SciencesMedicineEpidemiologyOpen Access
Read Source

National and regional estimates of term and preterm babies born small for gestational age in 138 low-income and middle-income countries in 2010

Verified

Anne CC Lee, Joanne Katz, Hannah Blencowe, Simon Cousens et al.

Journal: The Lancet Global HealthYear: 2013Citations: 856

BACKGROUND: National estimates for the numbers of babies born small for gestational age and the comorbidity with preterm birth are unavailable. We aimed to estimate the prevalence of term and preterm babies born small for gestational age (term-SGA and preterm-SGA), and the relation to low birthweigh...

Health SciencesMedicinePediatrics, Perinatology and Child HealthOpen Access
Read Source

Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers

Verified

Justina X. Caushi, Jiajia Zhang, Zhicheng Ji, Ajay Vaghasia et al.

Journal: NatureYear: 2021Citations: 543

Abstract PD-1 blockade unleashes CD8 T cells 1 , including those specific for mutation-associated neoantigens (MANA), but factors in the tumour microenvironment can inhibit these T cell responses. Single-cell transcriptomics have revealed global T cell dysfunction programs in tumour-infiltrating lym...

Health SciencesMedicineOncologyOpen Access
Read Source

Count every newborn; a measurement improvement roadmap for coverage data

Verified

Sarah G. Moxon, Harriet Ruysen, Kate Kerber, Agbessi Amouzou et al.

Journal: BMC Pregnancy and ChildbirthYear: 2015Citations: 366

BACKGROUND: The Every Newborn Action Plan (ENAP), launched in 2014, aims to end preventable newborn deaths and stillbirths, with national targets of ≤12 neonatal deaths per 1000 live births and ≤12 stillbirths per 1000 total births by 2030. This requires ambitious improvement of the data on care at ...

Health SciencesMedicinePediatrics, Perinatology and Child HealthOpen Access
Read Source

International caesarean section rates: the rising tide

Verified

Christine L. Roberts, Tanya Nippita

Journal: The Lancet Global HealthYear: 2015Citations: 61

Historically, the introduction of caesarean section surgery was associated with an improvement in maternal and perinatal health outcomes. WHO has stated that no empirical evidence exists for an ideal caesarean rate, but “what matters most is that all women who need caesarean sections actually receiv...

Health SciencesMedicineObstetrics and GynecologyOpen Access
Read Source

Enhancing quality midwifery care in humanitarian and fragile settings: a systematic review of interventions, support systems and enabling environments

Verified

Caroline Homer, Sabera Turkmani, Alyce N. Wilson, Joshua P. Vogel et al.

Journal: BMJ Global HealthYear: 2022Citations: 44

INTRODUCTION: Women and children bear a substantial burden of the impact of conflict and instability. The number of people living in humanitarian and fragile settings (HFS) has increased significantly over the last decade. The provision of essential maternal and newborn healthcare by midwives is cru...

Health SciencesMedicinePediatrics, Perinatology and Child HealthOpen Access
Read Source

Inequalities in women’s utilization of postnatal care services in Bangladesh from 2004 to 2017

Verified

Samia Aziz, Abdul Basit, Saima Sultana, Caroline Homer et al.

Journal: Scientific ReportsYear: 2022Citations: 34

Postnatal care (PNC) is an essential component of maternity care. Appropriate and timely care immediately after childbirth can save lives and help to prevent or treat comorbidities resulting from pregnancy and childbirth. Despite its importance, PNC coverage is still low in Bangladesh. The aim of th...

Health SciencesMedicinePediatrics, Perinatology and Child HealthOpen Access
Read Source

Antenatal dexamethasone for improving preterm newborn outcomes in low-resource countries: a cost-effectiveness analysis of the WHO ACTION-I trial

Verified

Katherine E. Eddy, Joshua P. Vogel, Nick Scott, Dagnachew Fetene et al.

Journal: The Lancet Global HealthYear: 2022Citations: 21

BACKGROUND: After considerable debate, there is now unequivocal evidence that use of antenatal corticosteroids improves outcomes in preterm neonates when used in women at risk of early preterm birth in reasonably equipped hospitals in low-resource countries. We aimed to evaluate the cost-effectivene...

Health SciencesMedicinePulmonary and Respiratory MedicineOpen Access
Read Source

Effect of dexamethasone on newborn survival at different administration-to-birth intervals: A secondary analysis of the WHO ACTION (Antenatal CorticosTeroids for Improving Outcomes in Preterm Newborn)-I trial

Verified

Olufemi T. Oladapo, Joshua P. Vogel, Gilda Piaggio, My Huong Nguyen et al.

Journal: EClinicalMedicineYear: 2022Citations: 17

Background: The WHO ACTION-I trial demonstrated that dexamethasone significantly reduced neonatal mortality when administered to women at risk of early preterm birth in low-resource countries. We conducted a secondary analysis to determine how these benefits can be optimised, by evaluating the effec...

Health SciencesMedicinePulmonary and Respiratory MedicineOpen Access
Read Source

The World Health Organization Antenatal CorTicosteroids for Improving Outcomes in preterm Newborns (ACTION-III) Trial: study protocol for a multi-country, multi-centre, double-blind, three-arm, placebo-controlled, individually randomized trial of antenatal corticosteroids for women at high probability of late preterm birth in hospitals in low- resource countries

Verified

WHO ACTION Trials Collaborators, Temitope Adesiji Adegboyega, Ebunoluwa A. Adejuyigbe, Olubukola Adesina et al.

Journal: TrialsYear: 2024Citations: 9

BACKGROUND: Preterm birth complications are the leading cause of newborn and under-5 mortality. Over 85% of all preterm births occur in the late preterm period, i.e. between 34 and < 37 weeks of gestation. Antenatal corticosteroids (ACS) prevent mortality and respiratory morbidity when administered ...

Health SciencesMedicinePulmonary and Respiratory MedicineOpen Access
Read Source

The efficacy of antenatal corticosteroids to improve preterm newborn outcomes in low‐resource countries: Are we there yet?

Verified

Saima Sultana, Joshua P. Vogel, Olufemi T. Oladapo

Journal: BJOG An International Journal of Obstetrics & GynaecologyYear: 2023Citations: 7

Preterm birth is defined by the World Health Organization (WHO) as a birth before 37 completed weeks of gestation or fewer than 259 days since the first day of a woman's last menstrual period.1 Globally, preterm birth is estimated to affect 10.6% (95% CI 9.0–12.0) of all pregnant women, equating to ...

Health SciencesMedicinePulmonary and Respiratory MedicineOpen Access
Read Source

The World Health Organization Antenatal CorTicosteroids for Improving Outcomes in preterm Newborns (ACTION-III) Trial: study protocol for a multi-country, multi-centre, double-blind, three-arm, placebo-controlled, individually randomized trial of antenatal corticosteroids for women at high probability of late preterm birth in hospitals in low- and middle-income countries

Verified

Temitope Adesiji Adegboyega, Ebunoluwa A. Adejuyigbe, Olubukola Adesina, Babalola Adeyemi et al.

Journal: Research SquareYear: 2023Citations: 1

Background: Preterm birth complications are the leading cause of newborn and under-5 mortality. Over 85% of all preterm births occur in the late preterm period i.e., between 34 and Methods: WHO ACTION III trial is a parallel-group, three-arm, individually randomized, double-blind, placebo-controlled...

Health SciencesMedicinePulmonary and Respiratory MedicineOpen Access
Read Source

Antenatal dexamethasone for preterm birth and long-term health outcomes in children: a pilot follow-up cohort study of ACTION-I trial participants in Sylhet, Bangladesh

Verified

Saima Sultana, Iffat Ara Jaben, Tamsasul Farha, Roy Sk et al.

Journal: BMJ Paediatrics OpenYear: 2025

Background The WHO ACTION-I trial in 2020 demonstrated the short-term efficacy and safety of antenatal dexamethasone for women at risk of early preterm birth in low-resource settings. However, the long-term effects of antenatal corticosteroids remain unclear, and no long-term follow-up studies have ...

Health SciencesMedicinePulmonary and Respiratory MedicineOpen Access
Read Source
PreviousPage 1 of 1Next